Related Experiment Video
Updated: Oct 9, 2025

Quantitative Visualization of Leukocyte Infiltrate in a Murine Model of Fulminant Myocarditis by Light Sheet Microscopy
Published on: May 31, 2017
Leukocytoclastic vasculitis after COVID-19 vaccination
1Department of Dermatology and Venereology, Istanbul Medipol University, Istanbul, Turkey.
Abstract:
Leukocytoclastic vasculitis (LCV) is the vasculitis of small vessels. In this report, we describe a 38-year-old male patient who presented to our outpatient clinic with a 1-week history of rash on his lower extremities that had started 4 days after receiving the Pfizer-BioNTech SARS-CoV-2 vaccine. A diagnosis of LCV was made based on clinical and histopathological findings. The patient was treated with antihistamines and prednisolone, after which improvement was observed in the lesions. With this paper, we aim to raise awareness concerning the possibility of LCV development after COVID-19 vaccination.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis I: Introduction
Myocarditis III: Medical Management
Pericarditis I: Introduction

